These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23438150)

  • 1. Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.
    Avirović M; Matušan-Ilijaš K; Damante G; Fabrro D; Cerović R; Juretić M; Grahovac B; Jonjić N; Lučin K
    J Oral Pathol Med; 2013 Sep; 42(8):620-6. PubMed ID: 23438150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
    Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
    Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive study on the prognostic role of osteopontin expression in oral squamous cell carcinoma.
    Chien CY; Su CY; Chuang HC; Fang FM; Huang HY; Chen CH; Chen CM; Huang CC
    Oral Oncol; 2009 Sep; 45(9):798-802. PubMed ID: 19213594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
    Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.
    Klimowicz AC; Bose P; Nakoneshny SC; Dean M; Huang L; Chandarana S; Magliocco AM; Wayne Matthews T; Brockton NT; Dort JC
    Eur J Cancer; 2012 Sep; 48(14):2166-74. PubMed ID: 22892062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
    Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
    Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
    Fujii N; Shomori K; Shiomi T; Nakabayashi M; Takeda C; Ryoke K; Ito H
    J Oral Pathol Med; 2012 Jul; 41(6):444-51. PubMed ID: 22296275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
    Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
    J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.
    Pappa E; Nikitakis N; Vlachodimitropoulos D; Avgoustidis D; Oktseloglou V; Papadogeorgakis N
    J Oral Maxillofac Surg; 2014 Jan; 72(1):211-21. PubMed ID: 23992782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
    Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
    Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
    J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR and Ki-67 expression in oral squamous cell carcinoma using tissue microarray technology.
    Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Forteza J; Fraga M
    J Oral Pathol Med; 2010 Aug; 39(7):571-8. PubMed ID: 20202087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midkine expression in oral squamous cell carcinoma and leukoplakia.
    Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
    J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
    Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial and stromal syndecan-1 and -2 are distinctly expressed in oral- and cutaneous squamous cell carcinomas.
    Ahmed Haji Omar A; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Salo T; Hagström J; Sorsa T
    J Oral Pathol Med; 2013 May; 42(5):389-95. PubMed ID: 23278563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
    Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.